SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,051,369 | -8.3% | 521,253 | +4.0% | 0.00% | -33.3% |
| Q2 2023 | $13,138,815 | +49.7% | 501,099 | +47.0% | 0.00% | +50.0% |
| Q1 2023 | $8,776,825 | +0.1% | 340,980 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $8,769,896 | -0.4% | 337,174 | +9.3% | 0.00% | 0.0% |
| Q3 2022 | $8,801,000 | +18.9% | 308,487 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $7,399,000 | -52.8% | 300,521 | +8.1% | 0.00% | -33.3% |
| Q1 2022 | $15,690,000 | -16.0% | 277,984 | -7.8% | 0.00% | 0.0% |
| Q4 2021 | $18,689,000 | -2.1% | 301,533 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $19,085,000 | -28.0% | 300,839 | -6.5% | 0.00% | -40.0% |
| Q2 2021 | $26,523,000 | +21.8% | 321,848 | +8.8% | 0.01% | +25.0% |
| Q1 2021 | $21,772,000 | -6.8% | 295,925 | -8.2% | 0.00% | -20.0% |
| Q4 2020 | $23,367,000 | +66.3% | 322,221 | +9.4% | 0.01% | +66.7% |
| Q3 2020 | $14,047,000 | +17.6% | 294,647 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $11,947,000 | +212.4% | 284,448 | +100.9% | 0.00% | +200.0% |
| Q1 2020 | $3,824,000 | -25.0% | 141,612 | +6.8% | 0.00% | 0.0% |
| Q4 2019 | $5,102,000 | +1198.2% | 132,553 | +631.4% | 0.00% | – |
| Q3 2019 | $393,000 | – | 18,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |